期刊文献+

喀什维吾尔族妇女宫颈癌与HLA-DRB1*15和HLA-DRB1*04的关系 被引量:13

The relationships between HLA-DRB1*15 or HLA-DRB1*04 and cervical cancer in Kashgar Uyghur women
下载PDF
导出
摘要 目的探讨人类白细胞抗原HLA-DRB1等位基因多态性与新疆宫颈癌高发区喀什维吾尔族妇女宫颈癌的关系。方法采用聚合酶联反应序列特异性寡核苷酸探针(polymerase chain reaction sequence-specificoligonucleotide,PCR-SSO)法检测90例新疆喀什维吾尔族宫颈癌患者及90例当地正常妇女宫颈组织中HLA-DRB1的等位基因。结果等位基因HLA-DRB1*15在宫颈癌组中出现的频率明显高于对照组,差异有统计学意义(χ2=4.05,P<0.05,OR=2.002),表明HLA-DRB1*15可能是喀什维吾尔族妇女宫颈癌的易感基因;而等位基因HLA-DRB1*04在宫颈癌组中出现的频率明显低于对照组,差异有统计学意义(χ2=7.283,P<0.05,OR=0.432),表明HLA-DRB1*04可能是喀什维吾尔族妇女宫颈癌的保护基因;HLA-DRB1的其他等位基因在两组中出现的频率差异无统计学意义(P>0.05)。结论 HLA-DRB1*15可能与新疆宫颈癌高发区喀什维吾尔族妇女对宫颈癌的遗传易感性有关,是当地维吾尔族妇女宫颈癌的易感基因;而HLA-DRB1*04可能是喀什维吾尔族妇女宫颈癌的保护基因。两组基因的检测在维族妇女高危人群的筛选及群体遗传干预工作中有重要意义。 Objective To investigate the relationships between the HLA-DRB1 allele polymorphisms and the Uyghur women's susceptibility to cervical carcinomas. Methods The HLA-DRB1 alleles were detected in 90 cervical cancer patients and 90 cases of control whom all from Kashgar by using the polymerase chain reaction sequence-specific oligonucleotide(PCR-SSO) method. Results The frequency of HLA-DRB1*15 in cervical cancer was significantly higher than that in the control group(χ2=4.05,P0.05,OR=2.002),while the frequency of HLA-DRB1*04 was significantly lower than that in the control group(χ2=4.05,P0.05,OR=2.002).The frequencies of other HLA-DRB1 alleles did not show statistical differences between the two groups. Conclusions HLA-DRB1*15 allele may be the susceptible gene to cervical cancer in the Uyghur women from Kashgar,while HLA-DRB1*04 allele may be the protective gene.Detecting of the two genes in high risk population may play an important role in screening and interferencing researches of cervical cancer in Uyghur women.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2010年第5期555-559,共5页 Fudan University Journal of Medical Sciences
基金 国家自然科学基金项目(30360107)
关键词 宫颈癌 喀什维吾尔族 人类白细胞抗原 等位基因多态性 遗传易感性 新疆 cervical cancer Kashgar Uyghur human leukocyte antigen allele polymorphism susceptibility Xinjiang
  • 相关文献

参考文献35

  • 1Yang L,Wang LJ,Shi GL,et al.Analysis of HLA-A,HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer[J].Genet Mol Res,2010,27(2):750-755.
  • 2Wang SS,Abdou AM,Morton LM,et al.Human leukocyte antigen class Ⅰ and Ⅱ alleles in non-Hodgkin lymphoma etiology[J].Blood,2010,115(23):4 820-4 823.
  • 3Amoli MM,Yazdani N,Amiri P,et al.HLA-DR association in papillary thyroid carcinoma[J].Dis Markers,2010,28(1):49-53.
  • 4Kohaar I,Hussain S,Thakur N,et al.Association between human leukocyte antigen class Ⅱ alleles and human papillomavirus-mediated cervical cancer in Indian women[J].Hum Immunol,2009,70(4):222-229.
  • 5Srivastava MK,Bosch JJ,Wilson AL,et al.MHC Ⅱ lung cancer vaccines prime and boost tumor-specific CD4+T cells that cross-react with multiple histologic subtypes of non-small cell lung cancer cells[J].Int J Cancer,2010,10(2):254-262.
  • 6Fernandes TA,Fukai R,Souza CA,et al.Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias[J].Blood Cells Mol Dis,2010,44(2):69-73.
  • 7Kübler K,Arndt PF,Wardelmann E,et al.Genetic alterations of HLA-class Ⅱ in ovarian cancer[J].Int J Cancer,2008,123(6):1 350-1 356.
  • 8Mehta AM,Jordanova ES,Kenter GG,et al.Association of antigen processing machinery and HLA class Ⅰ defects with clinicopathological outcome in cervical carcinoma Cancer[J].Immunol Immunother,2008,57(2):197-206.
  • 9de Araujo Souza PS,Sichero L,Maciag PC.HPV variants and HLA polymorphisms:the role of variability on the risk of cervical cancer[J].Future Oncol,2009,5(3):359-370.
  • 10Madeleine MM,Johnson LG,Smith AG,et al.Comprehensive analysis of HLA-A,HLA-B,HLA-C,HLA-DRB1,and HLA-DQB1 loci and squamous cell cervical cancer risk[J].Cancer Res,2008,68:3 532-3 539.

二级参考文献78

共引文献236

同被引文献155

引证文献13

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部